Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis
Open Access
- 19 November 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 16920
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Gpnmb is classified as a type 1 membrane protein and its soluble form is secreted by ADAM10-mediated cleavage. Gpnmb mRNA was found in the Kupffer cells and white adipose tissues (WATs) and its upregulation in obesity was recently found. Here, we generated aP2 promoter-driven Gpnmb transgenic (Tg) mice and the overexpression of Gpnmb ameliorated the fat accumulation and fibrosis of the liver in diet-induced obesity model. Soluble form of Gpnmb in sera was elevated in Gpnmb Tg mice and Gpnmb concentrated in hepatic macrophages and stellate cells interacted with calnexin, which resulted in the reduction of oxidative stress. In the patients with non-alcoholic steatohepatitis, serum soluble GPNMB concentrations were higher compared with the patients with simple steatosis. The GPNMB is a promising biomarker and therapeutic target for the development and progression of NAFLD in obesity.Keywords
This publication has 51 references indexed in Scilit:
- The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosisScientific Reports, 2012
- Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosisCell Death & Disease, 2011
- Homeodomain transcription factors regulate BMP‐2‐induced osteoactivin transcription in osteoblastsJournal of Cellular Physiology, 2011
- ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic PropertiesPLOS ONE, 2010
- DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T CellsCancer Research, 2010
- The DC‐HIL/syndecan‐4 pathway inhibits human allogeneic T‐cell responsesEuropean Journal of Immunology, 2009
- Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?Breast Cancer Research, 2007
- DC-HIL is a negative regulator of T lymphocyte activationBlood, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer ModelJournal of Biological Chemistry, 2003